Literature DB >> 2433590

The GTP-binding protein, Go, regulates neuronal calcium channels.

J Hescheler, W Rosenthal, W Trautwein, G Schultz.   

Abstract

In neuronal cells, opioid peptides and opiates inhibit neurotransmitter release, which is a calcium-dependent process. They also inhibit adenylyl cyclase, presumably via the membrane signal-transducing component, Gi, a guanine nucleotide-binding protein (G-protein). No causal relationship between these two events has yet been demonstrated. Besides Gi, membranes of neuronal tissues contain large amounts of Go, a G-protein with unknown function. Both G-proteins are heterotrimers consisting of alpha-, beta- and gamma-subunits; the alpha-subunits can be ADP-ribosylated by an exotoxin from Bordetella pertussis (PT), which modification inhibits receptor-mediated activation of the G-protein. It was recently shown that noradrenaline, dopamine and gamma-aminobutyric acid (GABA) inhibit the voltage-dependent calcium channels in dorsal root and sympathetic ganglia; this inhibition is mimicked by intracellular application of guanine nucleotides and blocked by PT, suggesting the involvement of a G-protein. Here we report an inhibitory effect of the opioid D-Ala2, D-Leu5-enkephalin (DADLE) on the calcium current (ICa) in neuroblastoma X glioma hybrid cells (N X G cells). Pretreatment with PT almost completely abolishes the DADLE effect. The effect is restored by intracellular application of Gi and Go. As the alpha-subunit of Go (with or without beta-gamma complex) is 10 times more potent than Gi, we propose that Go is involved in the functional coupling of opiate receptors to neuronal voltage-dependent calcium channels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433590     DOI: 10.1038/325445a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  166 in total

1.  Decreased G-protein-mediated regulation and shift in calcium channel types with age in hippocampal cultures.

Authors:  E M Blalock; N M Porter; P W Landfield
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons.

Authors:  C G Acosta; H S López
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

3.  Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture.

Authors:  C M Norris; E M Blalock; K-C Chen; N M Porter; P W Landfield
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

4.  G-protein coupling of mu-opioid receptors (OP3): elevated basal signalling activity.

Authors:  N T Burford; D Wang; W Sadée
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 5.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Guanosine-5'-O-(3-thiotriphosphate) modifies kinetics of voltage-dependent calcium current in chick sensory neurons.

Authors:  C Marchetti; M Robello
Journal:  Biophys J       Date:  1989-12       Impact factor: 4.033

7.  Elevated levels of the alpha subunit of GTP-binding protein Go in cerebrospinal fluid of patients with neurological disorders.

Authors:  T Murayama; A Takahashi; T Asano; K Kato
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

8.  Neuronal expression of a newly identified Drosophila melanogaster G protein alpha 0 subunit.

Authors:  C J Schmidt; S Garen-Fazio; Y K Chow; E J Neer
Journal:  Cell Regul       Date:  1989-11

9.  Mechanisms of antagonistic action of internal Ca2+ on serotonin-induced potentiation of Ca2+ currents in Helix neurones.

Authors:  P G Kostyuk; E A Lukyanetz
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

10.  Alpha 1-adrenoceptor-mediated inhibition of cellular cAMP accumulation in neonatal rat ventricular myocytes.

Authors:  S Barrett; N Honbo; J S Karliner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.